GlassScriptPhysician profile
Juan Guillermo Bastidas
NPI 1033301080
$14,365.86
in general payments reported to CMS, 2019-2025
31 companies · $1,752 in 2025
The $1,752 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,936 · 2020: $3,761 · 2021: $297 · 2022: $213 · 2023: $435 · 2024: $971 · 2025: $1,752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,073 · Travel and Lodging: $1,067 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,073.35 |
| Travel and Lodging | $1,067.28 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,776.55 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $1,293.22 | 2019-2025 | Advantagerib, Ribfix Titan, Ribfix Blu Advantage |
| Davol INC. | $654.28 | 2019-2025 | Progel Applicator Spray Tips |
| Atricure, INC. | $455.81 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Edwards Lifesciences Corporation | $373.93 | 2019-2025 | Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia, Konect Resilia |
| Medtronic, INC. | $301.68 | 2022-2025 | Corevalve Evolut R, Endurant Iis, Penditure |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $239.39 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $175.79 | 2024-2025 | Imfinzi |
| Ethicon US, LLC | $158.00 | 2019-2024 | Echelon; Endopath, Echelon Endopath, Harmonic |
| Livanova USA, INC. | $115.81 | 2019-2020 | |
| Getinge USA Sales, LLC | $96.10 | 2021-2024 | Vasoview Hemopro 2 |
| Medtronic Vascular, INC. | $94.38 | 2020 | |
| Corcym INC | $90.15 | 2021 | |
| Smith+Nephew, INC. | $88.09 | 2019-2025 | Pico 7, Renasys Go V2 Home, Collagenase Santyl |
| Merck Sharp & Dohme LLC | $71.92 | 2024-2025 | Keytruda |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $43.67 | 2023-2024 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $36.97 | 2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $35.37 | 2025 | |
| Ethicon INC. | $34.24 | 2025 | Monarch Platform |
| Solventum Corporation | $27.21 | 2024 | Prevena, V.A.C. Veraflo |
| Abiomed | $23.97 | 2024 | Impella |
| Philips North America LLC | $22.60 | 2025 | Vest Therapy Und |
| On Target Laboratories, INC | $22.32 | 2025 | Cytalux |
| Janssen Pharmaceuticals, INC | $22.07 | 2022 | |
| Werfen USA LLC | $20.85 | 2023 | |
| Abbott Laboratories | $18.03 | 2023 | Epic |
| Silk Road Medical, INC. | $17.44 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Pacira Pharmaceuticals Incorporated | $15.95 | 2025 | Exparel |
| Medistim USA, INC. | $13.77 | 2020 | |
| Baxter Healthcare | $13.21 | 2023 | Floseal |
| Angiodynamics, INC. | $13.09 | 2024 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Bastidas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.